PDRX (PD-RX Pharmaceuticals) Ending Cash Position: $0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PD-RX Pharmaceuticals Ending Cash Position?

PD-RX Pharmaceuticals PDRX Ending Cash Position is $0.00 Mil as of . 20.

PD-RX Pharmaceuticals's Ending Cash Position for the quarter that ended in . 20 was $0.00 Mil.


PD-RX Pharmaceuticals Ending Cash Position Related Terms


PD-RX Pharmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for PD-RX Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PD-RX Pharmaceuticals Ending Cash Position Chart

PD-RX Pharmaceuticals Annual Data
Trend
Ending Cash Position

PD-RX Pharmaceuticals Quarterly Data
Ending Cash Position

PD-RX Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PD-RX Pharmaceuticals's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

PD-RX Pharmaceuticals's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.00 Mil mean?
PD-RX Pharmaceuticals (PDRX) has a Ending Cash Position of $0.00 Mil as of . 20. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PD-RX Pharmaceuticals and its competitors.
Is PD-RX Pharmaceuticals' Ending Cash Position too high?
PD-RX Pharmaceuticals' current Ending Cash Position is $0.00 Mil.
How does PD-RX Pharmaceuticals' Ending Cash Position compare to SNYR and FZMD?
PD-RX Pharmaceuticals' Ending Cash Position of $0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Distribution company?
A good Ending Cash Position depends on the Medical Distribution industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PD-RX Pharmaceuticals and its competitors. PD-RX Pharmaceuticals's current Ending Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PD-RX Pharmaceuticals stock overvalued right now?
PD-RX Pharmaceuticals (PDRX) has a current Ending Cash Position of $0.00 Mil. The current Ending Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For PD-RX Pharmaceuticals (PDRX), the current Ending Cash Position is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PD-RX Pharmaceuticals Business Description

Address 727 North Ann Arbor Avenue, Oklahoma City, OK, USA, 73127-5822
PD-RX Pharmaceuticals Inc provides and distributes a complete line of brand and generic pharmaceuticals, unit dose products, unit of use, injectables, creams, ointments, and medical and surgical supplies.